FMP
NASDAQ
4.53 USD
0.04 (0.883%)
Dr. Carl L.G. Hansen Ph.D.
Healthcare
Biotechnology
https://www.abcellera.com
NASDAQ
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or under contract with 36 partners. AbCellera Biologics Inc. has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.
0001703057
CA00288U1066
00288U106
2215 Yukon Street
604 559 9005
CA
586
Dec 11, 2020
0001703057
NASDAQ
Biotechnology
Healthcare
00288U106
CA00288U1066
CA
4.53
0.38
1.46M
1.33B
-
3.87-8.05
-4.02
-
-
-
-
-8.88
-
https://www.abcellera.com
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load the chart at this time.
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
It looks like there's no news available.